External Source

Ipsen’s Current Rare Disease Therapies: Approved And In Development

2025 15:38
Synopsis
Christelle Huguet, PhD, Head of Research and Development at Ipsen, discusses the company's current approved orphan drugs ...

You Might Also Like

Ipsen is a Rare Disease Company 1:03
Ipsen Is A Rare Disease Company
2015
Securing Progress: PDUFA’s Role in Rare Disease Drug Development 52:25
Securing Progress: Pdufa’s Role In Rare Disease Drug Devel...
2025
Rare Disease Drug Development Education Series Trailer 1:50
Rare Disease Drug Development Education Series Trailer
2023
Ipsen Biopharmaceuticals Patient-Focused Approach to Rare Diseases 1:26
Ipsen Biopharmaceuticals Patient-focused Approach To Rare Di...
2021
300 million dollars in federal funding to develop treatments for rare diseases 1:57
300 Million Dollars In Federal Funding To Develop Treatments...
2015
Ipsen Biopharmaceuticals Commitment to Fibrodysplasia Ossificans Progressiva (FOP) 0:54
Ipsen Biopharmaceuticals Commitment To Fibrodysplasia Ossifi...
2021
Harnessing AI for Rare Disease Research and Patient Caregiving 59:20
Harnessing Ai For Rare Disease Research And Patient Caregivi...
2025
Rare Disease : Innovations in Diagnostics and Therapeutics (Cycle #2) - TEASER 4:28
Rare Disease : Innovations In Diagnostics And Therapeutics (...
2022
Trending in Rare Diseases: Europe’s R&D Risks, FDA Approvals & More 4:54
Trending In Rare Diseases: Europe’s R&d Risks, Fda Approva...
2025
Webinar - Personalized therapies in rare disease (Teaser) 4:11
Webinar - Personalized Therapies In Rare Disease (teaser)
2022
How Rare Disease Treatments Get Approved 3:24
How Rare Disease Treatments Get Approved
2020
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.